MLS PHARMA
ActiveSummary
MLS PHARMA has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €437,939 and a net result of €197,555. Equity is growing by about 33% per year across the filed financial years. The computed 12-month bankruptcy probability is below 0.1% (very low).
Directors
Directors
No directors read yet: 1 of 2 Gazette acts processed. See the directors and other office holders in the KBO →
Owners and capital
Owners
No owners or capital events in the accounts and acts we read.